A detailed history of Thrive Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Thrive Wealth Management, LLC holds 6,160 shares of ABBV stock, worth $1.1 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
6,160
Previous 6,167 0.11%
Holding current value
$1.1 Million
Previous $1.06 Million 15.04%
% of portfolio
0.22%
Previous 0.21%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

SELL
$163.84 - $199.33 $1,146 - $1,395
-7 Reduced 0.11%
6,160 $1.22 Million
Q2 2024

Jul 12, 2024

SELL
$154.79 - $180.76 $30,338 - $35,428
-196 Reduced 3.08%
6,167 $1.06 Million
Q1 2024

Apr 15, 2024

BUY
$159.82 - $182.1 $92,375 - $105,253
578 Added 9.99%
6,363 $1.16 Million
Q4 2023

Jan 09, 2024

SELL
$137.6 - $154.97 $45,545 - $51,295
-331 Reduced 5.41%
5,785 $896,000
Q3 2023

Oct 13, 2023

BUY
$133.59 - $154.65 $72,672 - $84,129
544 Added 9.76%
6,116 $911,000
Q2 2023

Jul 11, 2023

BUY
$132.51 - $164.9 $137,015 - $170,506
1,034 Added 22.79%
5,572 $750,000
Q1 2023

Apr 07, 2023

BUY
$144.61 - $166.54 $10,990 - $12,657
76 Added 1.7%
4,538 $723,000
Q4 2022

Jan 25, 2023

BUY
$138.31 - $165.87 $133,469 - $160,064
965 Added 27.6%
4,462 $0
Q3 2022

Oct 24, 2022

BUY
$134.21 - $153.93 $14,226 - $16,316
106 Added 3.13%
3,497 $469,000
Q2 2022

Jul 11, 2022

BUY
$137.62 - $174.96 $43,763 - $55,637
318 Added 10.35%
3,391 $519,000
Q1 2022

May 02, 2022

BUY
$131.98 - $163.75 $95,421 - $118,391
723 Added 30.77%
3,073 $498,000
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $252,460 - $319,435
2,350 New
2,350 $318,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Thrive Wealth Management, LLC Portfolio

Follow Thrive Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrive Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thrive Wealth Management, LLC with notifications on news.